U.S. IT Stock News

NYSE:AMN
NYSE:AMNHealthcare

AMN Healthcare Services (AMN) Stock After 103.6% Yearly Surge Is The Valuation Justified

Wondering whether AMN Healthcare Services at around US$30.79 is offering value right now or just catching your eye after a big move. The stock is up 0.6% over the last week and 4.5% over the past month, with a 103.6% return year to date and a 42.4% gain over the last year, even though the share price has fallen 71.6% over three years and 67.7% over five years. Recent coverage has focused on how AMN Healthcare Services fits into investor interest around healthcare staffing and workforce...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Plug Power’s Margin Repair And Leadership Shift Refocus Investor Attention

Plug Power (NasdaqCM:PLUG) reports sharply improved margins and tighter cost controls, highlighting early signs of an operational turnaround. The company outlines progress on its Project Quantum Leap initiative, targeting leaner operations and better capital discipline. New CEO José Luis Crespo accelerates a shift toward vertical integration, including more in house hydrogen production capacity. Management frames these changes as a structural move toward profitability in Plug Power's...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Stock Valuation Check After Recent Gains And Merger Expectations

Renasant (RNST) has drawn fresh attention after recent share price moves, with the stock last closing at $42.26. Investors are weighing this performance against the bank's mix of community banking and wealth management operations. See our latest analysis for Renasant. Recent trading has come on the back of a firm run in the share price, with a 30 day share price return of 6.72% feeding into a 19.48% year to date gain and a 20.93% 1 year total shareholder return. This suggests that momentum...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Is Up 6.1% After Early In Vivo CAR-T Data for LB2501 – What's Changed

Legend Biotech recently reported early Phase 1 data for LB2501, an investigational in vivo CD19/CD20 dual-targeting CAR-T therapy in relapsed/refractory B-cell non-Hodgkin lymphoma, showing high response rates, dose-dependent in vivo CAR-T expansion, and a manageable safety profile without lymphodepleting chemotherapy. The ability of LB2501 to generate CAR-T cells directly inside patients from a single off-the-shelf infusion could materially simplify treatment logistics compared with...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Equinix (EQIX) Stock After 36% YTD Rally Is Growth Already Priced In?

This article examines whether Equinix, at around US$1,043 per share, is offering good value or embedding high future expectations, by breaking down what the current price might be implying. Over the past week the stock is down 4.2% and over the past month it is down 3.5%. Year to date it is up 36.5% and over the last year it has returned 19.0%, which naturally raises questions about how much of that performance is already reflected in the price. Over the last three and five years, Equinix...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy And Depop Push For Rules That Could Reshape Resale Economics

Etsy (NYSE:ETSY) and its subsidiary Depop have released a joint whitepaper calling for regulatory reforms to support the circular economy and secondhand market. The paper urges policymakers to update rules, reduce administrative and tax frictions, and provide more support for microbusinesses selling pre owned goods. This move highlights Etsy's effort to influence policy around resale activity and align its marketplace with emerging circular economy priorities. Etsy runs a global marketplace...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Nutanix Community Project Adds New Angle To Stock Valuation Story

Nutanix (NasdaqGS:NTNX) has partnered with San José Mineta International Airport to open The Nest by Nutanix, a sensory-friendly room for children with autism and sensory sensitivities. The dedicated space is now available to traveling families at SJC, offering a calmer environment before boarding. This initiative adds a community focused dimension to Nutanix’s profile, which is typically centered on its software and cloud offerings. Nutanix, trading at around $49.21 per share, has seen...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Astera Labs Joins Nasdaq-100 As AI Connectivity Momentum Meets Valuation Tension

Astera Labs (NasdaqGS:ALAB) is scheduled to be added to the Nasdaq-100 Index in June 2026. This index inclusion marks a key milestone in the company’s public life and recognition within the AI infrastructure sector. The move may affect how global investors and index-tracking funds gain exposure to the stock. For investors tracking AI hardware, Astera Labs now sits alongside some of the largest US-listed companies through its upcoming addition to the Nasdaq-100 Index. The stock trades at...
NYSE:CBRE
NYSE:CBREReal Estate

CBRE Promotion Highlights Growth Outlook And Undervalued Stock Opportunity

CBRE Group (NYSE:CBRE) has promoted Jeremy Chism to managing director and market leader for Memphis and Jackson, Mississippi. The appointment places an experienced executive over key Southeast markets, with responsibilities across multiple property types. The move comes as CBRE is recognized for strong financial and operational performance and a solid outlook for growth. For you as an investor, this promotion speaks directly to how CBRE Group, a global commercial real estate services...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

The Bull Case For Datadog (DDOG) Could Change Following Its Big AI And Security Push – Learn Why

At its recent DASH user conference, Datadog unveiled more than 100 new AI and security capabilities, including major enhancements to its Bits AI platform, AI Guard for protecting AI agents, and Bring Your Own Cloud to keep data processing within customers’ own environments. The event has prompted a wave of upbeat analyst commentary, with many viewing Datadog’s push toward autonomous observability and AI security as a meaningful expansion of its role in monitoring and controlling modern AI...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher Scientific (TMO) Stock After Volatile Year Is There Still Upside Potential

Investors may be wondering whether Thermo Fisher Scientific, at around US$475 per share, still offers value or if most of the opportunity is already priced in. The stock is up 14.9% over the past year, even though it is down 19.7% year to date and only slightly higher over the last month. This may have shifted how investors see its risk and reward trade off. Recent headlines have focused on Thermo Fisher Scientific's role across pharmaceuticals, biotech and lab tools. This keeps attention on...
NYSE:BCC
NYSE:BCCTrade Distributors

Boise Cascade (BCC) Stock Valuation After Revenue Decline And Ongoing Payout Commitments

Boise Cascade (BCC) recently reported Q1 2026 results showing a 2% revenue decline, as softer demand in its Building Materials Distribution and Wood Products segments met headwinds from adverse weather, geopolitical tensions, and volatile mortgage rates. See our latest analysis for Boise Cascade. The recent Q1 2026 update comes after a mixed period for the stock, with a 30 day share price return of 4.02% and a 1 year total shareholder return that declined 18.83%, signaling fading momentum...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Virgin Galactic Reshapes Finances And Governance Ahead Of 2026 Commercial Flights

Virgin Galactic Holdings (NYSE:SPCE) has converted a portion of its debt into equity, which reduces future cash interest payments and extends debt maturities. The company has resolved governance related claims through a settlement that includes corporate reforms. These steps come as Virgin Galactic targets key flight tests in Q3 and the start of commercial operations in Q4 2026. For investors watching NYSE:SPCE, these balance sheet and governance changes arrive after a sharp move in the...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments (TXN) Stock After 67% YTD Surge Is The Current Price Justified

If you are wondering whether Texas Instruments' current share price still offers value, it helps to step back and look at what the recent returns and valuation checks are really telling you. The stock closed at US$297.10, with the share price down 2.7% over the last 7 days, slightly up 0.7% over the last month, and showing returns of 67.4% year to date and 53.0% over the past year. Recent coverage has focused on the stock's multi year share price performance, with returns of 82.1% over 3...
NYSE:OUT
NYSE:OUTSpecialized REITs

The Bull Case For OUTFRONT Media (OUT) Could Change Following New Debt Refi And Equity Shelf Filing

OUTFRONT Media Inc. recently completed a US$500.0 million private offering of 6.000% senior notes due 2034 and filed a US$105.44 million shelf registration for 3,373,000 common shares tied to an ESOP-related offering, both aimed at past balance sheet management and funding flexibility. Together, the refinancing of its 5.000% senior notes due 2027 and the new equity shelf expand OUTFRONT Media’s financial options to support its ongoing digital billboard and transit investments. We’ll now...
NYSE:SBH
NYSE:SBHSpecialty Retail

Sally Beauty (SBH) Stock After Q2 Beat Is A 27.9% Undervalued Story Or Fairly Priced Winner

Sally Beauty Holdings (SBH) just reported fiscal second quarter 2026 results that topped earnings and sales estimates, with gross margin gains linked to its Fuel for Growth program and ongoing e commerce momentum. See our latest analysis for Sally Beauty Holdings. The fiscal second quarter beat appears to have shifted sentiment quickly, with the share price up 3.67% in the last day and a 7 day share price return of 13.19%. The 1 year total shareholder return of 51.51% sits against a weaker 5...
NasdaqCM:OTLK
NasdaqCM:OTLKBiotechs

Outlook Therapeutics (OTLK) Stock After FDA Class 1 BLA Resubmission Is The Valuation Out Of Line

Outlook Therapeutics (OTLK) has moved back into focus after resubmitting its Biologics License Application to the FDA for ONS-5010/LYTENAVA for wet age related macular degeneration, following a successful appeal of a prior Complete Response Letter. See our latest analysis for Outlook Therapeutics. Investors appear to be reacting to the BLA resubmission and upcoming FDA decision. The latest share price is US$1.10, with a 30 day share price return of 353.61%. However, the 1 year total...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings (DKNG) Stock Valuation After Predictions Platform Growth And Rising Trading Volumes

Predictions surge puts DraftKings stock in focus DraftKings (DKNG) is back on many watchlists after its Predictions platform reported rapid month over month growth in May, with higher consumer trading volumes drawing fresh attention to the stock. See our latest analysis for DraftKings. The Predictions update comes on top of a sharp near term rebound, with a 1 day share price return of 4.27%, a 7 day return of 18.33% and a 30 day return of 21.98%. However, the stock is still down year to date...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

JDcom (JD) Stock Valuation Check After Recent Weak Share Price Performance

JD.com (NasdaqGS:JD) has drawn fresh attention after recent trading left the stock down about 11% over the past month and roughly 14% over the past year, prompting investors to reassess its current valuation. See our latest analysis for JD.com. The recent 1 month share price return of down 10.9%, combined with a 1 year total shareholder return decline of 13.6%, points to fading momentum as investors reassess JD.com’s risk and growth profile around its current US$28.06 share price. If this...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM) Stock After Breakthrough Liver Disease Data And Upcoming Volixibat NDA Valuation Check

Mirum Pharmaceuticals (MIRM) has drawn fresh attention after presenting late breaking Phase 2b data for volixibat in primary sclerosing cholangitis and brelovitug in hepatitis delta virus, alongside regulatory progress toward a planned volixibat New Drug Application. See our latest analysis for Mirum Pharmaceuticals. The recent late breaking trial results arrive after a year where Mirum’s share price return is up 27.5% year to date, while the 1 year total shareholder return is 103.06%. This...
NYSE:FLUT
NYSE:FLUTHospitality

Flutter Entertainment (NYSE:FLUT) Stock Valuation After World Cup Betting Growth And FanDuel Predicts Momentum

Flutter Entertainment (NYSE:FLUT) is back in focus after management highlighted expectations for up to 100,000 bets per minute during the 2026 FIFA World Cup. The company sees the tournament as a key driver of customer acquisition. See our latest analysis for Flutter Entertainment. Even with World Cup excitement and recent boardroom changes, Flutter’s share price tells a mixed story, with a 15.46% 1 month share price return and a year to date share price decline of 49.24%, while the 1 year...
NasdaqGS:RNW
NasdaqGS:RNWRenewable Energy

Analyst Upgrades to Earnings Outlook Could Be A Game Changer For ReNew Energy Global (RNW)

Recently, analysts raised their earnings estimates for ReNew Energy Global, with the stock now carrying a stronger Zacks Rank that reflects improving earnings expectations. This shift in analyst sentiment highlights how perceived earnings momentum can influence investor confidence in a renewable power producer like ReNew. Next, we’ll examine how these upward earnings estimate revisions may influence ReNew Energy Global’s broader investment narrative and risk-reward profile. The future of...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Corebridge Financial (CRBG) Is Up 6.7% After Winning Exclusive US$500 Million Baltimore Schools Mandate

In early June 2026, Baltimore City Public Schools selected Corebridge Financial as the sole provider for its 403(b) and 457(b) retirement plans, consolidating roughly 10,000 participants and about US$500 million in assets from 12 providers into a single, lower-fee platform. This long-standing relationship evolving into an exclusive mandate highlights Corebridge’s competitive strength in group retirement, combining reduced participant costs with broader investment options and personalized...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

Why G-III Apparel Group (GIII) Is Up 11.3% After Raising Earnings Guidance Despite Lower Sales

G-III Apparel Group recently reported past first-quarter fiscal 2027 results showing net sales of US$535.96 million and a sharp increase in net income to US$66.53 million, and raised its earnings guidance for the fiscal year ending January 31, 2027, despite anticipating lower sales of approximately US$2.71 billion after losing Calvin Klein and Tommy Hilfiger business. Management highlighted that the earnings outlook improvement comes as the company accelerates its shift toward higher-margin...